As of Feb 12
| +0.13 / +2.02%|
The 4 analysts offering 12-month price forecasts for Syneron Medical Ltd have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +90.26% increase from the last price of 6.57.
The current consensus among 4 polled investment analysts is to Buy stock in Syneron Medical Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.